hotspot -WSS

hotspot

author：fashion 2025-08-24 10:14:59 - browse：988

Akero Therapeutics said Tuesday that an experimental medicine failed to show a significant benefit for patients with cirrhosis caused by NASH, the most advanced and life-threatening stage of the fatty liver disease.

While the study’s primary goal of improving liver fibrosis, or scarring, was not achieved, the Akero drug, called efruxifermin, outperformed placebo by 10 percentage points. The drug also resolved NASH symptoms, including reductions in liver fat and inflammation, and improved other markers of the disease.

“These are the best data reported to date for any NASH drug in this patient population,” said Kitty Yale, Akero’s chief development officer. “We missed the primary endpoint. We understand that, but there’s actually a lot of hope when you look at the totality of the data.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Will.i.am, Britney Spears release new single, 'Mind Your Business'

focus

WSS

White House launches permanent pandemic office

AbbVie dramatically boosts its spending on lobbying

What to know about Saharan dust affecting the US and how it can affect health

NVIDIA and Google execs on the future of AI and drug discovery

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Venture capitalist Bob Kocher on the state of digital health

entertainment

hotspot

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Cytokinetics CEO stresses company can launch heart drug on its own

Drug repurposing or repositioning? The language matters

Readers respond to H5N1 and livestock movements, and more

BioMarin wins approval for gene therapy to treat hemophilia A

When prostate cancer spreads, where it goes matters

The high cost of giving birth even with insurance

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Tori Bowie and the unacceptable rates of Black maternal death

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

focus

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Russian special forces kill a gunman who broke into a private house near Moscow

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Arc Institute generative AI designs new CRISPR systems

Providers still hesitate to prescribe buprenorphine, study finds

Our daughter's deadly disease: trisomy 18. We wanted to protect her

hotspot

focus

hotspot

Wikipedia